BriaCell Therapeutics ^Investors

BriaCell Therapeutics is a biotechnology company based in New York, New York, founded in 2004 The company specializes in the development of immunotherapy treatments for cancer, with a focus on breast cancer BriaCell has attracted significant investment from various angel groups, reflecting strong confidence in its innovative approach to cancer treatment The firm is dedicated to advancing its clinical programs and expanding its portfolio of therapeutic options for patients With a commitment to scientific excellence, BriaCell aims to make a meaningful impact in the field of oncology